- Home
- BTCT vs SBFM Comparison
BTCT vs SBFM Comparison
Compare BTCT & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTCT
- SBFM
- Stock Information
- Founded
- BTCT 2006
- SBFM 2006
- Country
- BTCT China
- SBFM United States
- Employees
- BTCT N/A
- SBFM N/A
- Industry
- BTCT Other Consumer Services
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- BTCT Real Estate
- SBFM Health Care
- Exchange
- BTCT Nasdaq
- SBFM Nasdaq
- Market Cap
- BTCT 4.4M
- SBFM 3.7M
- IPO Year
- BTCT N/A
- SBFM N/A
- Fundamental
- Price
- BTCT $19.27
- SBFM $2.35
- Analyst Decision
- BTCT
- SBFM
- Analyst Count
- BTCT 0
- SBFM 0
- Target Price
- BTCT N/A
- SBFM N/A
- AVG Volume (30 Days)
- BTCT 10.1M
- SBFM 151.4K
- Earning Date
- BTCT 11-26-2024
- SBFM 11-05-2024
- Dividend Yield
- BTCT N/A
- SBFM N/A
- EPS Growth
- BTCT N/A
- SBFM N/A
- EPS
- BTCT N/A
- SBFM N/A
- Revenue
- BTCT $8,482,000.00
- SBFM $32,959,491.00
- Revenue This Year
- BTCT $11.07
- SBFM $86.70
- Revenue Next Year
- BTCT $5.27
- SBFM $126.76
- P/E Ratio
- BTCT N/A
- SBFM N/A
- Revenue Growth
- BTCT N/A
- SBFM 61.94
- 52 Week Low
- BTCT $1.32
- SBFM $2.25
- 52 Week High
- BTCT $26.58
- SBFM $638.00
- Technical
- Relative Strength Index (RSI)
- BTCT 94.61
- SBFM 25.54
- Support Level
- BTCT $1.78
- SBFM $2.58
- Resistance Level
- BTCT $26.58
- SBFM $2.86
- Average True Range (ATR)
- BTCT 2.76
- SBFM 0.17
- MACD
- BTCT 2.07
- SBFM -0.04
- Stochastic Oscillator
- BTCT 70.74
- SBFM 12.67
About BTCT BTC Digital Ltd.
BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.